Physician profile
Crystal A Smith
NPI 1659317675
$350.76
in general payments reported to CMS, 2019-2025
11 companies · $88.61 in 2025
The $88.61 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.10 · 2023: $43.71 · 2024: $190 · 2025: $88.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $68.59 | 2024 | Versacross Access Solution, Watchman Flx |
| Sanofi-Aventis U.S. LLC | $48.06 | 2025 | |
| Medtronic, INC. | $43.71 | 2023 | Corevalve Evolut R |
| Exact Sciences Corporation | $40.41 | 2024 | Cologuard Collection Kit |
| Abiomed | $38.09 | 2024 | Impella |
| Abbvie INC. | $28.10 | 2022 | |
| Novo Nordisk INC | $23.27 | 2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $17.28 | 2025 | Mounjaro, Zepbound |
| Sandoz INC. | $14.51 | 2024 | Hyrimoz |
| Pfizer INC. | $14.43 | 2024 | |
| Amgen INC. | $14.31 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.